Capio AB (publ) has entered an agreement to acquire 100% interest in healthcare and dental care services provider Novakliniken.

The healthcare services company will have 28 primary care centres and 220,000 listed patients in Skane region, upon completion of the acquisition in April 2018.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Both companies involved in the acquisition are based in Sweden.

BioStem Technologies Inc has agreed to purchase Grupo Impulso De Incentivacion Para Nuevas Tecnologias (GIINT).

GIINT will become a wholly owned subsidiary of BioStem upon completion of the acquisition.

Based in Mexico, the acquiring company is a life sciences company involved in the development of pharmaceutical and regenerative medicine products.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
“GIINT will become a wholly owned subsidiary of BioStem upon completion of the acquisition.”

GIINT is based in Mexico and is a biotechnology company involved in stem cell research and development.

The acquisition will strengthen BioStem’s stem cell business.

Virtus Health Limited has signed an agreement to purchase 90% of Complete Fertility Limited (CFL) for £5m ($6.95m).

The business and assets related to fertility services provided by the University Hospital Southampton NHS Foundation Trust (UHS) are also part of the acquisition.

Virtus Health is an Australian healthcare services provider, while CFL is a fertility care provider based in the UK.

The transaction is expected to be closed by the end of this month.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact